Journal
CELL TRANSPLANTATION
Volume 19, Issue 6-7, Pages 655-665Publisher
SAGE PUBLICATIONS INC
DOI: 10.3727/096368910X508753
Keywords
Cell transplant; Organ engineering; Decellularized matrices; Natural scaffolds
Funding
- American Liver Foundation
- US National Institutes of Health (NIH) [K99DK083556-01]
- NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R00DK083556, K99DK083556, R01DK084053] Funding Source: NIH RePORTER
Ask authors/readers for more resources
Cell populations derived from adult tissue and stem cells possess a great expectation for the treatment of several diseases. Great efforts have been made to generate cells with therapeutic impact from stem cells. However, it is clear that the development of systems to deliver such cells to induce efficient engraftment, growth, and function is a real necessity. Biologic and artificial scaffolds have received significant attention for their potential therapeutic application when use to form tissues in vitro and facilitate engraftment in vivo. Ultimately more sophisticated methods for decellularization of organs have been successfully used in tissue engineering and regenerative medicine applications. These decellularized tissues and organs appear to provide bioactive molecules and bioinductive properties to induce homing, differentiation, and proliferation of cells. The combination of decellularized organs and stem cells may dramatically improve the survival, engraftment, and fate control of transplanted stem cells and their ultimate clinical utility, opening the doors to a new era of organ engineering.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available